Compare · FLNC vs TMO
FLNC vs TMO
Side-by-side comparison of Fluence Energy Inc. (FLNC) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- FLNC operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $197.88B, about 76.3x FLNC ($2.59B).
- Over the past year, FLNC is up 56.9% and TMO is up 28.1% - FLNC leads by 28.7 points.
- Both names hit the wire about 9 times in the past 4 weeks.
- Both have 25 recent analyst ratings on file.
- Company
- Fluence Energy Inc.
- Thermo Fisher Scientific Inc
- Price
- $14.07-2.39%
- $532.16-2.05%
- Market cap
- $2.59B
- $197.88B
- 1M return
- -41.17%
- +12.59%
- 1Y return
- +56.86%
- +28.12%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 9
- 9
- Recent ratings
- 25
- 25
Fluence Energy Inc.
Fluence Energy, Inc. provides energy storage products and services, and digital applications for renewables and storage applications worldwide. The company sells energy storage products with integrated hardware, software, and digital intelligence, as well as engineering and delivery services to support the deployment of its storage products; operational and maintenance, and energy storage-as-a-service; and digital applications and solutions. It serves utilities, developers, and commercial and industrial customers. The company was founded in 2018 and is headquartered in Arlington, Virginia. Fluence Energy, LLC operates as a subsidiary of Siemens Aktiengesellschaft and The AES Corporation.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest FLNC
- Fluence Retains Tier 1 Energy Storage Supplier Status in S&P Global Energy 2026 Cleantech List
- Truist initiated coverage on Fluence with a new price target
- Fluence to Provide U.S. Domestic Content Smartstack System for Avantus 800 MWh Rexford 2 Project in Southern California
- Large owner Spt Holding Sarl disposed of 20,462,735 shares (SEC Form 4)
- AI Energy Pivot Complete: LIXTE Biotechnology Finishes Corporate Rebrand to NOMAD Power Solutions, Begins Trading Under Nasdaq: NMAD
- Amendment: SVP & CCSO Zahurancik John sold $754,703 worth of shares (31,974 units at $23.60) as part of a pre-agreed trading plan, decreasing direct ownership by 31% to 71,171 units (SEC Form 4)
- SVP & CCSO Zahurancik John sold $754,703 worth of shares (31,974 units at $23.60), decreasing direct ownership by 31% to 71,171 units (SEC Form 4)
- Fluence Advances Smartstack Energy Storage Platform with High-Density 10 MWh System
- SEC Form 144 filed by Fluence Energy Inc.
- A Nasdaq Company Just Reinvented Itself as a Power Company — and Bet It All on the AI Energy Crunch
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target